1021937-07-4 Usage
Uses
Used in Pharmaceutical Industry:
2-(4-(2-(4-(2,2-Dimethylbutyl)-1H-imidazol-2-yl)ethyl)phenyl)pyridine is used as a potential pharmaceutical agent for its unique structure and properties. Its complex molecular architecture allows for interactions with various biological targets, making it a candidate for the development of new drugs with specific therapeutic effects.
Used in Agrochemical Industry:
In the agrochemical industry, 2-(4-(2-(4-(2,2-Dimethylbutyl)-1H-imidazol-2-yl)ethyl)phenyl)pyridine is used as a potential active ingredient in pesticides or herbicides. Its unique structure may provide novel modes of action, leading to the development of more effective and selective agrochemicals.
Used in Materials Science:
2-(4-(2-(4-(2,2-Dimethylbutyl)-1H-imidazol-2-yl)ethyl)phenyl)pyridine is used in materials science for its potential to contribute to the development of new materials with specific properties. Its complex molecular structure may enable the creation of materials with unique electronic, optical, or mechanical characteristics.
Further studies and research are necessary to fully understand the potential uses and properties of 2-(4-(2-(4-(2,2-Dimethylbutyl)-1H-imidazol-2-yl)ethyl)phenyl)pyridine, as its complex nature may offer a wide range of applications across different industries.
Check Digit Verification of cas no
The CAS Registry Mumber 1021937-07-4 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,2,1,9,3 and 7 respectively; the second part has 2 digits, 0 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1021937-07:
(9*1)+(8*0)+(7*2)+(6*1)+(5*9)+(4*3)+(3*7)+(2*0)+(1*7)=114
114 % 10 = 4
So 1021937-07-4 is a valid CAS Registry Number.
1021937-07-4Relevant academic research and scientific papers
Synthesis and SAR of derivatives based on 2-biarylethylimidazole as bombesin receptor subtype-3 (BRS-3) agonists for the treatment of obesity
Liu, Jian,He, Shuwen,Jian, Tianying,Dobbelaar, Peter H.,Sebhat, Iyassu K.,Lin, Linus S.,Goodman, Allan,Guo, Cheng,Guzzo, Peter R.,Hadden, Mark,Henderson, Alan J.,Pattamana, Kevin,Ruenz, Megan,Sargent, Bruce J,Swenson, Brian,Yet, Larry,Tamvakopoulos, Constantin,Peng, Qianping,Pan, Jie,Kan, Yanqing,Palyha, Oksana,Kelly, Theresa M.,Guan, Xiao-Ming,Howard, Andrew D.,Marsh, Donald J.,Metzger, Joseph M.,Reitman, Marc L.,Wyvratt, Matthew J.,Nargund, Ravi P.
scheme or table, p. 2074 - 2077 (2010/07/03)
This Letter describes a series of potent and selective BRS-3 agonists containing a biarylethylimidazole pharmacophore. Extensive SAR studies were carried out with different aryl substitutions. This work led to the identification of a compound 2-{2-[4-(pyridin-2-yl)phenyl]ethyl}-5-(2,2-dimethylbutyl)-1H-imidazole 9 with excellent binding affinity (IC50 = 18 nM, hBRS-3) and functional agonist activity (EC50 = 47 nM, 99% activation). After oral administration, compound 9 had sufficient exposure in diet induced obese mice to demonstrate efficacy in lowering food intake and body weight via BRS-3 activation.
